Explicyte Immuno-Oncology & Cancer Immunotherapy
Explicyte Immuno-Oncology & Cancer Immunotherapy
sept 2022
NEW IN VIVO SHUTTLE CAMPAIGN!
09 / 08 / 2022
| |
 |
NEW IN VIVO SHUTTLE CAMPAIGN!
What if you take advantage of our next shuttle session to get to know us & benefit from our services in a cost-saving way?
Save the date, start is early November! You can already register by filling out the form below.
|
|
| |
We are committed to providing world-class supports to advance your preclinical projects and immunotherapy drug discovery. These supports are carried out using syngeneic tumor mouse models through our comprehensive in vivo Immuno-Oncology platform, as illustrated thereafter.
Click on each icon for more details
|
|
| |
In vivo
efficacy |
|
Immune response
profiling |
|
TME
featuring |
|
Clustering & differential
gene expression analysis |
|
